Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 15, 2018
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
Wed, March 14, 2018
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
Tue, March 13, 2018
[ Tue, Mar 13th 2018
] - WOPRAI
[ Tue, Mar 13th 2018
] - WOPRAI
[ Tue, Mar 13th 2018
] - WOPRAI
[ Tue, Mar 13th 2018
] - WOPRAI
[ Tue, Mar 13th 2018
] - WOPRAI
[ Tue, Mar 13th 2018
] - WOPRAI
Geoffrey Porges Maintained (WVE) at Buy with Decreased Target to $62 on, Mar 13th, 2018
Geoffrey Porges of Leerink Swann, Maintained "Wave Life Sciences Ltd." (WVE) at Buy with Decreased Target from $64 to $62 on, Mar 13th, 2018.
Geoffrey has made no other calls on WVE in the last 4 months.
There is 1 other peer that has a rating on WVE. Out of the 1 peers that are also analyzing WVE, 0 agree with Geoffrey's Rating of Hold.
This is the rating of the analyst that currently disagrees with Geoffrey
- Paul Matteis of "Leerink Swann" Maintained at Buy with Increased Target to $64 on, Wednesday, February 21st, 2018
